Exparel 1.3% 20ML 10S
Ended Awarded
- Contract number
- SPE2DX25FKVZF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,064
Award facts
- Contract value 100% obligated
- $15,063.78 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, with the place of performance in Park Ridge, Illinois and an ultimate completion date of September 3, 2025. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting Department of Defense healthcare facilities worldwide.
EXPAREL is a liposomal bupivacaine injectable anesthetic used for infiltration and nerve blocks in surgical settings, representing one of many specialty pharmaceutical products within the vendor's extensive portfolio. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets. The company's contract awards demonstrate consistent delivery of high-value pharmaceutical items including prescription medications, biologics, vaccines, and medical devices to military and federal healthcare systems across the nation.
Quick answers
Who was awarded contract SPE2DX25FKVZF?
SPE2DX25FKVZF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2DX25FKVZF worth?
The government has obligated $15,064 on SPE2DX25FKVZF.
Is contract SPE2DX25FKVZF an order under another contract?
Yes. SPE2DX25FKVZF is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVZF competed?
The extent of competition for SPE2DX25FKVZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award